Stocksigma LogoStocksigma Logo

Catalyst Trusteeship Acquires 47.95% Share Pledge in Bliss GVS Pharma

Catalyst Trusteeship Limited, acting as debenture trustee on behalf of debenture holders, acquired an encumbrance via pledge over 5,09,84,595 equity shares

Catalyst Trusteeship Acquires 47.95% Share Pledge in Bliss GVS Pharma

Bliss GVS Pharma Ltd 路 Acquisition/ Disposal of Shares 路 06 Oct 2026, 3:56 pm

Catalyst Trusteeship Acquires 47.95% Share Pledge in Bliss GVS Pharma Catalyst Trusteeship Limited, acting as debenture trustee on behalf of debenture holders, acquired an encumbrance via pledge over 5,09,84,595 equity shares of Bliss GVS Pharma Ltd on 30th Sep'26. The transaction represents 47.95% of the company's total voting capital and 46.77% of its total diluted share capital. Prior to this event, the acquirer held no shares or voting rights in the target company. Bliss GVS Pharma's total equity base stands at 10,63,30,472 shares, with a diluted capital base of 10,90,11,222 shares.

Original exchange filing (PDF)

More announcements from Bliss GVS Pharma Ltd

All Bliss GVS Pharma Ltd announcements